Product Program year 2021 Source: CMS Open Payments

Xenleta

Drug Antibiotic

NDC 72000-120-06

Open in the dashboard

General payments

$82,790

3,093 payments

Research payments

$0

0 payments

Through program year 2021, $82,790 in general payments and $0 in research payments were reported against Xenleta (Antibiotic).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $26,775 1,702
2020 General $56,015 1,391

Breakdown

Who paid General payments · program years 2020–2021
  1. Nabriva Therapeutics, plc $82,790 3,093 payments
Top recipients General payments · program year 2021
  1. Raymond Collier Family Medicine · Lubbock, TX $172 <1% · 12 payments
  2. Ikenna Onyebueke Critical Care Medicine · Spartanburg, SC $113 <1% · 6 payments
  3. Rajesh Patel Internal Medicine · Media, PA $101 <1% · 6 payments
  4. Gaurav Patel Sleep Medicine · Media, PA $101 <1% · 6 payments
  5. Russell Daily Physician Assistant · Keller, TX $97 <1% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Family Medicine $5,783 22% · 270 practitioners
  2. Internal Medicine $5,453 21% · 243 practitioners
  3. Pulmonary Disease Internal Medicine $3,872 15% · 171 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $2,570 10% · 130 practitioners
  5. Infectious Disease Internal Medicine $1,973 7% · 106 practitioners

The top 5 of 43 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Texas $2,888 11% · 123 recipients
  2. Florida $2,376 9% · 141 recipients
  3. New York $2,184 8% · 75 recipients
  4. New Jersey $2,014 8% · 89 recipients
  5. California $1,535 6% · 71 recipients

The top 5 of 43 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

3,093 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record